ZA906834B - Dibenz(b,f)(1,4)oxazepin(and thiazepin)-11(10h)-ones and-thiones and their use in aids therapy - Google Patents

Dibenz(b,f)(1,4)oxazepin(and thiazepin)-11(10h)-ones and-thiones and their use in aids therapy

Info

Publication number
ZA906834B
ZA906834B ZA906834A ZA906834A ZA906834B ZA 906834 B ZA906834 B ZA 906834B ZA 906834 A ZA906834 A ZA 906834A ZA 906834 A ZA906834 A ZA 906834A ZA 906834 B ZA906834 B ZA 906834B
Authority
ZA
South Africa
Prior art keywords
thiazepin
oxazepin
thiones
dibenz
ones
Prior art date
Application number
ZA906834A
Other languages
English (en)
Inventor
Karl D Hargrave
D Hargrave Karl
Guenther Schmidt
Schmidt Guenther
Wolfhard Engel
Engel Wolfhard
Kurt Schromm
Schromm Kurt
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA906834B publication Critical patent/ZA906834B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA906834A 1989-08-29 1990-08-28 Dibenz(b,f)(1,4)oxazepin(and thiazepin)-11(10h)-ones and-thiones and their use in aids therapy ZA906834B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40025489A 1989-08-29 1989-08-29

Publications (1)

Publication Number Publication Date
ZA906834B true ZA906834B (en) 1992-05-27

Family

ID=23582850

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906834A ZA906834B (en) 1989-08-29 1990-08-28 Dibenz(b,f)(1,4)oxazepin(and thiazepin)-11(10h)-ones and-thiones and their use in aids therapy

Country Status (13)

Country Link
US (1) US5571806A (da)
EP (1) EP0419861B1 (da)
JP (1) JP2862980B2 (da)
KR (1) KR0165108B1 (da)
AT (1) ATE129637T1 (da)
AU (1) AU639255B2 (da)
CA (1) CA2024040C (da)
DE (1) DE69023311T2 (da)
DK (1) DK0419861T3 (da)
GR (1) GR3018757T3 (da)
HU (1) HU211077B (da)
NZ (1) NZ235082A (da)
ZA (1) ZA906834B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109557D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
GB9109497D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
DE4122240A1 (de) * 1991-07-05 1993-01-07 Boehringer Mannheim Gmbh Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel
DE4138853A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11- oxime
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
EP1027337A4 (en) * 1997-09-04 2002-04-03 Smithkline Beecham Corp Integrin receptor Antagonist
WO2000000678A1 (en) * 1998-06-26 2000-01-06 University Of Washington Crystallization media
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
LT3324948T (lt) * 2015-07-17 2023-03-27 BE Pharbel Manufacturing Daugiasluoksnės farmaciniu požiūriu aktyvaus junginio atpalaidavimo mikrodalelės skystoje vaisto formoje
US11649218B2 (en) 2018-03-09 2023-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
KR102276547B1 (ko) * 2020-09-04 2021-07-13 주식회사유한양행 오메프라졸, 에스오메프라졸 또는 이의 약제학적으로 허용가능한 염을 포함하는 정제 형태의 약학 조성물 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1060786A (en) * 1963-10-09 1967-03-08 Wander Ag Dr A Process for the preparation of lactams
NL127795C (da) * 1966-01-28
US3546214A (en) * 1967-07-11 1970-12-08 Boehringer Sohn Ingelheim Amino-substituted dibenz(b,f)(1,4)oxazepin-11(10h)-ones
US3541085A (en) * 1969-05-09 1970-11-17 American Cyanamid Co Method of preparing thiotricyclic compounds
JPS572278A (en) * 1980-06-04 1982-01-07 Chugai Pharmaceut Co Ltd Dibenzoxazepin derivative
JPS57106673A (en) * 1980-12-24 1982-07-02 Chugai Pharmaceut Co Ltd Dibenzo(b,f)(1,4)oxazepin derivative
US4663317A (en) * 1984-04-18 1987-05-05 Board Of Regents, University Of Texas System Methods and compositions for treating viral infections
US4728735A (en) * 1984-10-15 1988-03-01 Merck & Co., Inc. 10,11-dihydro-dibenzo-[b,f][1,4]-thiazepin derivatives
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten

Also Published As

Publication number Publication date
ATE129637T1 (de) 1995-11-15
DK0419861T3 (da) 1996-03-04
EP0419861A3 (en) 1992-06-10
DE69023311D1 (de) 1995-12-07
CA2024040C (en) 2002-02-19
KR0165108B1 (ko) 1999-02-18
DE69023311T2 (de) 1996-04-25
JP2862980B2 (ja) 1999-03-03
NZ235082A (en) 1997-04-24
HU905511D0 (en) 1991-02-28
KR910004579A (ko) 1991-03-29
EP0419861A2 (en) 1991-04-03
EP0419861B1 (en) 1995-11-02
AU639255B2 (en) 1993-07-22
HUT57589A (en) 1991-12-30
JPH03163021A (ja) 1991-07-15
AU6191690A (en) 1991-03-07
HU211077B (en) 1995-10-30
US5571806A (en) 1996-11-05
GR3018757T3 (en) 1996-04-30
CA2024040A1 (en) 1991-03-01

Similar Documents

Publication Publication Date Title
CA2145300A1 (en) Fixture provided with micro-threads
AU581808B2 (en) Disposable diaper having an improved side closure
ZA906834B (en) Dibenz(b,f)(1,4)oxazepin(and thiazepin)-11(10h)-ones and-thiones and their use in aids therapy
HK1011025A1 (en) 5,11-Dihydro-6h-dipyrido¬3,2-b:2'3'-e¾¬1,4¾diazepines and their use in the preventionor treatment of hiv infection
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
ZA90245B (en) Treatment of diseases associated with hiv infections
ZA904991B (en) 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)-diazepin-6-ones and-thiones and their use for the treatment of aids
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
GR3015469T3 (en) 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS.
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
IL112183A0 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
EP0415304A3 (en) Dipyrido(3,2-b:2',3'-e)(1,4)oxazepin (and thiazepin)-6(5h)-ones and -thiones and their use in the prevention or treatment of aids
GR3018683T3 (en) Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection
AU8981891A (en) Use of certain esters of hexahydro-8-hydroxy-2,6-methano- 2h-quinolizin-3(4h)-one and related compounds for treating cognitive disorders
CA2452439A1 (en) Fixture provided with micro-threads
AU7141591A (en) Treatment of ocular hypertension with class i calcium channel blocking agents
ZA981198B (en) Treatment of hiv positive patients
MX9604346A (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido [3,2-b :2',3'-e] [1,4]diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
NZ314730A (en) Use of dideoxycytosine derivatives in the treatment of viral infection
OA09307A (en) "Pyrido /2, 3-b/ /1, 5/ benzoxazepin (and thiazepin) -5(6H) -ones and-thiones and their use in the prevention or treatment of HIV infection".
ZA951318B (en) 2-heteroaryl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4] diazepines and their use in the prevention or treatment of HIV infection
ZA983778B (en) Derivatives of 5-phenyl-1,3,4-oxadiazol-2(3H)-one their preparation and their application for therapeutic treatment